JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

Search

Envista Holdings Corp

Fermé

SecteurSoins de santé

22.9 -1.55

Résumé

Variation du prix de l'action

24h

Actuel

Min

22.73

Max

23.66

Chiffres clés

By Trading Economics

Revenu

-57M

-30M

Ventes

-12M

670M

P/E

Moyenne du Secteur

267.222

90.422

BPA

0.32

Marge bénéficiaire

-4.523

Employés

12,300

EBITDA

18M

97M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+4.69% upside

Dividendes

By Dow Jones

Prochains Résultats

5 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

613M

4B

Ouverture précédente

24.45

Clôture précédente

22.9

Sentiment de l'Actualité

By Acuity

50%

50%

147 / 352 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Envista Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 févr. 2026, 23:52 UTC

Acquisitions, Fusions, Rachats

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2 févr. 2026, 23:52 UTC

Acquisitions, Fusions, Rachats

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2 févr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2 févr. 2026, 23:38 UTC

Market Talk

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2 févr. 2026, 23:28 UTC

Market Talk

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2 févr. 2026, 23:23 UTC

Résultats

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2 févr. 2026, 22:57 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2 févr. 2026, 22:08 UTC

Market Talk

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2 févr. 2026, 21:51 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 févr. 2026, 21:49 UTC

Résultats

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2 févr. 2026, 21:39 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:36 UTC

Résultats

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2 févr. 2026, 21:34 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:28 UTC

Acquisitions, Fusions, Rachats

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2 févr. 2026, 21:23 UTC

Résultats

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2 févr. 2026, 21:19 UTC

Résultats

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2 févr. 2026, 21:17 UTC

Résultats

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2 févr. 2026, 21:17 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:10 UTC

Résultats

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 févr. 2026, 21:08 UTC

Résultats

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2 févr. 2026, 21:07 UTC

Résultats

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies 4Q Net $608.7M >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies 4Q Rev $1.41B >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies 4Q Adj EPS 25c >PLTR

2 févr. 2026, 21:05 UTC

Résultats

Palantir Technologies 4Q EPS 24c >PLTR

2 févr. 2026, 20:40 UTC

Market Talk

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Comparaison

Variation de prix

Envista Holdings Corp prévision

Objectif de Prix

By TipRanks

4.69% hausse

Prévisions sur 12 Mois

Moyen 24.57 USD  4.69%

Haut 28 USD

Bas 21 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

8 ratings

5

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

15.98 / N/ASupport & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

147 / 352Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
help-icon Live chat